CBPA4_HUMAN - dbPTM
CBPA4_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID CBPA4_HUMAN
UniProt AC Q9UI42
Protein Name Carboxypeptidase A4
Gene Name CPA4
Organism Homo sapiens (Human).
Sequence Length 421
Subcellular Localization Secreted.
Protein Description Metalloprotease that could be involved in the histone hyperacetylation pathway. [PubMed: 10383164 Releases a C-terminal amino acid, with preference for -Phe, -Leu, -Ile, -Met, -Tyr and -Val]
Protein Sequence MRWILFIGALIGSSICGQEKFFGDQVLRINVRNGDEISKLSQLVNSNNLKLNFWKSPSSFNRPVDVLVPSVSLQAFKSFLRSQGLEYAVTIEDLQALLDNEDDEMQHNEGQERSSNNFNYGAYHSLEAIYHEMDNIAADFPDLARRVKIGHSFENRPMYVLKFSTGKGVRRPAVWLNAGIHSREWISQATAIWTARKIVSDYQRDPAITSILEKMDIFLLPVANPDGYVYTQTQNRLWRKTRSRNPGSSCIGADPNRNWNASFAGKGASDNPCSEVYHGPHANSEVEVKSVVDFIQKHGNFKGFIDLHSYSQLLMYPYGYSVKKAPDAEELDKVARLAAKALASVSGTEYQVGPTCTTVYPASGSSIDWAYDNGIKFAFTFELRDTGTYGFLLPANQIIPTAEETWLGLKTIMEHVRDNLY
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
38PhosphorylationVRNGDEISKLSQLVN
ECCHHHHHHHHHHHH
26.04-
78PhosphorylationVSLQAFKSFLRSQGL
HHHHHHHHHHHHCCC
24.0624719451
210PhosphorylationQRDPAITSILEKMDI
CCCHHHHHHHHHCCE
21.0424719451
260N-linked_GlycosylationADPNRNWNASFAGKG
CCCCCCCCCCCCCCC
29.2915738388

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources

Oops, there are no upstream regulatory protein records of CBPA4_HUMAN !!

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of CBPA4_HUMAN !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of CBPA4_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
LXN_HUMANLXNphysical
15738388
NUCG_HUMANENDOGphysical
26186194

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
There are no disease associations of PTM sites.
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of CBPA4_HUMAN

loading...

Related Literatures of Post-Translational Modification
N-linked Glycosylation
ReferencePubMed
"Structure of human carboxypeptidase A4 with its endogenous proteininhibitor, latexin.";
Pallares I., Bonet R., Garcia-Castellanos R., Ventura S., Aviles F.X.,Vendrell J., Gomis-Rueth F.-X.;
Proc. Natl. Acad. Sci. U.S.A. 102:3978-3983(2005).
Cited for: X-RAY CRYSTALLOGRAPHY (1.6 ANGSTROMS) OF 114-421 IN COMPLEX WITH LXN,GLYCOSYLATION AT ASN-260, AND DISULFIDE BOND.
"Detailed molecular comparison between the inhibition mode of A/B-typecarboxypeptidases in the zymogen state and by the endogenous inhibitorlatexin.";
Garcia-Castellanos R., Bonet-Figueredo R., Pallares I., Ventura S.,Aviles F.X., Vendrell J., Gomis-Rueth F.-X.;
Cell. Mol. Life Sci. 62:1996-2014(2005).
Cited for: X-RAY CRYSTALLOGRAPHY (2.2 ANGSTROMS) OF 19-421 IN COMPLEX WITH LXNAND ZINC IONS, GLYCOSYLATION AT ASN-260, AND DISULFIDE BOND.

TOP